Revisions Log

A log of revisions to articles and news stories.

Jan 16 2024 - Main article image changed from a picture of a generic pill, to that of a transmission electron micrograph of SARS-CoV-2 virus particles. This was actioned to avoid confusion from the generic pill being a similar color to molnupiravir - an antiviral not mentioned in this study. This study is on the use of a standard dose of Paxlovid which consists of multiple tablets pink and white in color.

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Dec 14 2023 - We at NewsMedical are committed to upholding the highest standards of journalism, which include integrity, fairness, and respect for all individuals and communities. It has come to our attention that a recent piece published on our platform did not meet these standards, specifically in its use of language. After a thorough review, we have determined that the language used in the article does not align with our editorial guidelines and values, which prioritize respectful and unbiased reporting. We understand that the words we choose in our reporting can have a significant impact, and in this instance, we failed to meet our own standards of responsible journalism. As a result, we have made the decision to retract the article in question.

Speech or language impairments may not be linked to tantrums in children with autism

Nov 30 2023 - Title changed as misleading "Alcohol consumption may have counteractive effects on heart disease risk" to "Study suggests a complex metabolic basis between alcohol consumption and CVD". The original headline "Alcohol consumption may have counteractive effects on heart disease risk, study finds" does not accurately reflect the findings of the study. The research primarily identified 60 metabolites associated with long-term alcohol consumption and their complex relationship with cardiovascular disease (CVD). It didn't conclude that alcohol consumption has counteractive effects on heart disease risk but rather showed a complex metabolic basis between alcohol consumption and CVD.

Study suggests a complex metabolic basis between alcohol consumption and CVD

Nov 16 2023 - To address the concerns raised by the research team, the following changes should be made to the news article "Study highlights risks of high-dose naloxone in opioid overdose response": Correction of Administration Route: Replace all instances where 'intravenous naloxone' is mentioned with 'intranasal naloxone'. This error appears in the first paragraph, twice in the results section, and in the conclusion. Clarification of Naloxone Dosage: In the introduction and background, the term 'low-dose naloxone' should be corrected to 'standard dose naloxone'. The study compares standard dose naloxone with high-dose naloxone, and the current wording inaccurately suggests a focus on low-dose naloxone. Accurate Representation of the Research Team: Amend the 'About the study' section to reflect that the two members from Tennessee Harm Reduction were key members of the research team, not merely consultants. Correcting Efficacy Information: Remove or correct the statement claiming intranasal naloxone is less effective, as this does not align with the findings of the study. These revisions will ensure the article aligns accurately with the original research. The research team has offered their assistance for any further clarification required.

Study highlights risks of high-dose naloxone in opioid overdose response

Nov 2 2023 - Extra journal references added to reflect the new content added

Cancer Research

Nov 2 2023 - Updates added to Molecular basis of cancer and Cancer prevention and early detection

Cancer Research

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback